Note - they do not link anywhere yet.. that will be added soon.
Scroll down for inactive trials
Trials marked with a *** are duplicates

•  Vaccine: [1841] A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
•  NCT01609790: [2068] Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab with or without AMG 386 in Patients With Recurrent Glioblastoma or Gliosarcoma
•  NCT01587144: [2046] Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
•  NCT01502917: [2034] Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
•  NCT01498328: [2049] A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)
•  NCT01480479: [2048] Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
•  NCT01480050: [2045] Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma [New concept in treating brain tumors: Interlaced Therapy!]
•  NCT01478178: [2035] Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
•  NCT01470794: [2033] Study of a Retroviral Replicating Vector (Tocagen Toca 511) to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
•  NCT01331291: [2021] Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma
•  NCT01290692: [2030] Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
•  NCT01285414: [2015] A Phase 2 Study of Verubulin With Radiation Therapy and Temozolomide in Subjects Newly Diagnosed With Glioblastoma Multiforme
•  NCT01280552: [2013] A Study of ICT-107(Vaccine therapy) in Glioblastoma Multiforme (GBM)
•  NCT01268566: [2022] A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
•  NCT01260506: [2029] Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
•  NCT01227434: [2020] A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
•  NCT01226940: [1999] Lenalidomide and Radiation Therapy in Treating Young Patients With Pontine Glioma or High-Grade Glioma
•  NCT01222754: [2016] A Phase I Trial of Lenalidomide and Radiotherapy in Children With Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas
•  NCT01213407: [2023] Dendritic Cell Cancer Vaccine for High-grade Glioma
•  NCT01204684: [1995] Dendritic Cell Vaccine for Patients With Brain Tumors
•  NCT01172964: [1997] A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
•  NCT01156584: [1990] A Phase 1 Ascending Dose Trial of the Safety and Tolerability of Tocagen Toca 511 in Patients with Recurrent Glioblastoma Multiforme
•  NCT01144247: [2032] Phase I Clinical Trial Evaluating Cellular Immunotherapy With Intratumoral Alloreactive Cytotoxic T Lymphocytes and Interleukin-2 for the Treatment of Recurrent Malignant Gliomas
•  NCT01140568: [1993] A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas
•  NCT01128218: [2036] A Phase 1 and 2 Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
•  NCT01116661: [1998] A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
•  NCT01044966: [1967] A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
•  NCT01026168: [1954] A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
•  NCT01024907: [1966] Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
•  NCT01020292: [1955] A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
•  NCT01019434: [1957] Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
•  NCT01013285: [1958] Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT01006044: [1973] Prospective, Phase II Clinical Trial to Evaluate Efficacy and Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme Patients After Complete Surgical Resection With Fluorescence Microscope
•  NCT00996723: [1968] Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
•  * * * Duplicate ** NCT00996723: [1960] Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
•  NCT00978458: [2047] Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
•  NCT00948961: [2017] A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
•  NCT00936052: [1988] Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma (HBO)
•  NCT00935545: [2018] A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors
•  NCT00928226: [1939] Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
•  NCT00916409: [1924] Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
•  NCT00905060: [1972] PHASE II, Single-arm, Open-label Investigation of HSPPC-96 Vaccine With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00892931: [1926] Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme
•  NCT00890786: [1959] A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
•  NCT00890032: [1969] Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
•  NCT00884741: [1989] Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
•  * * * Duplicate ** NCT00884741: [1986] Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
•  NCT00880061: [1911] An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma
•  NCT00823459: [1902] Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma
•  NCT00813943: [1992] Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status (CORE)
•  NCT00795457: [2031] A Bi-Institutional Pilot Study to Evaluate the Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With WHO Grade II Low-Grade Gliomas
•  NCT00751270: [1974] A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
•  NCT00747253: [1892] Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
•  * * * Duplicate ** NCT00747253: [1879] AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors
•  NCT00734682: [1903] A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
•  NCT00727506: [2001] Phase I/II Trial of BIBW 2992 in Treating Patients With Recurrent Glioblastoma Multiforme
•  NCT00720356 : [2000] Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00704288: [1991] Study of XL184 in Adults With Glioblastoma Multiforme
•  NCT00694330: [1941] Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
•  NCT00689221: [1985] Cilengitide for Subjects With Newly Diagnosed Glioblastoma Multiforme and Methylated MGMT Gene Promoter - A Multicenter, Open-Label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone
•  NCT00639639: [1971] Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia
•  NCT00635557: [1925] Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
•  NCT00627224: [1845] Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe]
•  NCT00626990: [1987] Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
•  NCT00613223: [1940] Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
•  NCT00612001: [1843] Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients
•  NCT00600054: [1961] Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
•  NCT00589875: [1975] A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
•  NCT00589784: [1887] Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
•  NCT00589706: [1896] A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 (MAb-425) in High Grade Gliomas
•  NCT00586508: [1912] A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
•  NCT00576641: [1970] Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
•  NCT00576446: [1844] A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
•  NCT00562419: [1861] Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme
•  * * * Duplicate ** NCT00562419: [1886] CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
•  NCT00560144: [1921] Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
•  NCT00555399: [1859] Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme
•  NCT00516607: [1811] Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas
•  NCT00514397: [1962] Temozolomide (Temodar)and Radiation Therapy in Treating Young Patients With Pontine Glioma
•  NCT00509301: [1787] Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme
•  NCT00499798: [1785] Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
•  NCT00499473: [1812] A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas
•  NCT00498927: [1786] A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma
•  NCT00492687: [1809] A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas
•  NCT00482677: [1816] A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
•  NCT00473408: [1817] The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas
•  NCT00471653: [1826] A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide
•  NCT00463203: [1782] A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy
•  NCT00458601: [1765] Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
•  NCT00456612: [1825] Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status
•  NCT00452959: [1082] A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
•  NCT00450866: [1771] Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer
•  NCT00445965: [1808] Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
•  NCT00441142: [1793] Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
•  NCT00438997: [1918] A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
•  NCT00437047: [1922] A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
•  NCT00423735: [1797] RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
•  NCT00418899: [1784] Gliogene: Brain Tumor Linkage Study
•  NCT00400920: [1761] Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
•  NCT00400816: [1770] Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma
•  NCT00400322: [1888] Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection
•  NCT00397072: [1820] Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients
•  NCT00394628: [1745] A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme
•  NCT00392327: [1779] Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
•  NCT00390299: [1744] Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme
•  NCT00381797: [1893] Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
•  NCT00379080: [1766] A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma
•  NCT00360854: [1759] Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
•  NCT00354068: [1804] A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma
•  NCT00337207: [1803] A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas
•  NCT00335764: [1805] Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
•  NCT00329719: [1720] Phase I/II Study of Sorafenib and Temsirolimus (CCI-779) in Patients With Recurrent Glioblastoma
•  NCT00316849: [1735] Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00314808: [1703] A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas
•  NCT00313729: [1704] Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma
•  NCT00313664: [1914] A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
•  NCT00311857: [1710] Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial
•  NCT00311558: [1768] Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma
•  NCT00304044: [1920] AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab, Leucovorin Rescue and Highly Active Antiretroviral Therapy
•  NCT00304031: [1714] Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma
•  NCT00301418: [1695] Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
•  NCT00293566: [1917] A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
•  NCT00293423: [1688] Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma
•  NCT00290797: [1915] Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma
•  NCT00285324: [2019] Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
•  NCT00283543: [1716] A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion
•  NCT00280475: [1685] Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504)
•  NCT00276783: [1693] Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
•  NCT00275002: [1700] Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors
•  NCT00272870: [1702] A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection
•  NCT00268385: [1679] A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas
•  NCT00253721: [1639] Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors
•  NCT00253474: [936] A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron) for Plexiform Neurofibromas (NF1 patients)
•  NCT00250211: [1655] Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide
•  NCT00247403: [1681] Phase I Clinical Trial: 2DG (2-Deoxyglucose ) + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases
•  NCT00243022: [1633] Boswellia Serrata Combined With a Low-Fat, Vegan Diet or a Standard Diet Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed Glioblastoma Multiforme
•  NCT00238173: [1660] Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
•  NCT00213278: [1713] Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
•  NCT00209989: [1646] Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
•  NCT00209248: [851] PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma
•  NCT00207350: [1661] Neurosurgical Use of Interstitial Laser Therapy (ILT)
•  NCT00200161: [796] Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas
•  NCT00190424: [1630] Randomized Phase 2 with CpG-ODN in Malignant Glioblastoma
•  NCT00187642: [747] A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with Supratentorial Low Grade Glioma
•  NCT00179907: [1648] A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System
•  NCT00179881: [715] Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
•  NCT00132158: [1653] ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
•  NCT00128986: [1707] A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour
•  NCT00125710: [1709] Comparative 2-D Tumor Analysis in Familial Gliomas
•  NCT00124657: [1536] Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
•  NCT00114140: [1580] A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
•  NCT00112762: [1916] Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
•  NCT00112736: [1548] NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
•  NCT00112502: [955] Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
•  NCT00109798: [1510] Phase 2 Trial of Salvage Chemotherapy with Temozolomide in Combination with Topotecan for Primary CNS Lymphoma.
•  * * * Duplicate ** NCT00109798: [2003] Phase II Trial of Chemotherapy with Temozolomide in Combination with Topotecan for Central Nervous System (CNS) Metastases of Solid Tumors
•  NCT00107367: [1596] A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis
•  NCT00098865: [1592] Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
•  NCT00098605: [1608] Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
•  NCT00096265: [1604] Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
•  NCT00096252: [969] Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases
•  NCT00089245: [1601] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00087230: [1354] Intratumoral Transferrin-CRM107 (Transmid) Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme
•  NCT00085254: [1168] Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00085202: [1706] Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
•  NCT00084838: [1089] Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
•  NCT00083096: [1656] Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
•  NCT00080938: [1603] Temozolomide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
•  NCT00075387: [504] Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma
•  NCT00068510: [578] Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma)
•  * * * Duplicate ** NCT00068510: [1131] Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma)
•  NCT00060879: [1045] Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00058123: [1014] Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
•  NCT00054496: [1482] Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00052455: [1554] Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
•  NCT00052286: [1721] Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors
•  NCT00049127: [1347] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  * * * Duplicate ** NCT00049127: [1624] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  NCT00049023: [1598] Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
•  NCT00045968: [1750] Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer
•  NCT00042367: [749] Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants with Brain Tumors
•  NCT00041145: [1919] A Phase II Study of Pegylated Interferon Alfa-2b (PEG-INTRON) in Children With Diffuse Pontine Gliomas
•  NCT00039494: [1544] Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
•  NCT00036569: [967] A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron`) in Children with Diffuse Pontine Gliomas
•  NCT00031590: [804] Reduced Dose Craniospinal Radiation (1800 cGy) and Chemotherapy in children with newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor (PNET/medulloblastoma )
•  NCT00031577: [787] Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma.
•  NCT00004259: [1093] Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
•  NCT00004129: [1490] Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
•  NCT00003553: [1615] A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy
•  NCT00003514: [1599] Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
•  NCT00003476: [1587] Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
•  NCT00003475: [1563] Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
•  NCT00003458: [1585] Antineoplaston Therapy in Treating Children With Brain Tumors
•  NCT00003457: [1562] Antineoplaston Therapy in Treating Patients With Brain Tumors
•  NCT00002899: [1133] Whole Brain Radiation following surgical resection in patients with newly diagnosed brain metastases: A Phase III prospective randomized trial
•  NCT00002899 : [1026] No Radiotherapy versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases from Solid Tumor after Surgical Resection or Radiosurgery. A Randomized Phase III Trial.
•  NCT00002647: [381] Phase I study of Photodynamic Therapy with porfimer sodium for refractory brain tumors
•  NCT00001574: [1605] A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
•  NCT0000067232: [1367] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  Deleted: [2002] Effect of Novocure NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
•  01508221: [2061] A Phase II Trial to Evaluate the Use of Trental and Vitamin E for Prophalaxis of Radiation Necrosis
•  01475006: [2059] A Phase I First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII)
•  01417507: [2054] Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients with Supratentorial Low-Risk Grade II Glioma
•  01399372: [2053] Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
•  01026493: [2052] A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma
•  00795457: [1895] A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Adults with High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Inactive Trials

Note - these mighe be duplicates, or closed trials

•  NCT01171469: [2014] Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
•  NCT01081223: [1984] Phase I Study To Test The Safety of TVAX Immunotherapy As A Treatment For Recurrent Grade III/IV Gliomas
•  NCT00912951: [1930] PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme
•  NCT00626015: [1839] Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
•  NCT00539552: [1835] Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma
•  NCT00525525: [1858] A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma
•  NCT00424060: [1807] Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma
•  NCT00385853: [1792] A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma
•  NCT00362921: [1267] Phase II trial of Gliadel plus O6-Benzylguanine for patients with recurrent glioblastoma multiforme.
•  NCT00352521: [1814] Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab (Avastin) in Combination With Irinotecan (CPT-11) for Malignant Gliomas
•  NCT00275067: [1684] Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
•  NCT00268359: [1689] Phase II Study of Bevacizumab (Avastin) and Irinotecan Hydrochloride (CPT-11) in Patients With Recurrent or Refractory Grade 3 or 4 Malignant Gliomas
•  NCT00253448: [1644] Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
•  NCT00227032: [1635] Safety and Pharmacokinetics Study of Erlotinib (Tarceva) to Treat Patients with Recurrent Glioblastoma Multiforme.
•  * * * Duplicate ** NCT00227032: [1256] Phase II, multicenter, open-label trial of the safety and efficacy of Tarceva in patients with first relapse of grade IV glioma (glioblastoma multiforme)
•  NCT00179803: [1649] Phase II Prospective Study of Sequential Myeloablative Chemotherapy with Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors.
•  NCT00171938: [1645] Open-Label Trial of Imatinib Mesylate (Gleevec) in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
•  NCT00147056: [1654] A Feasibility Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Lesions
•  NCT00128700: [1641] Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00114309: [1739] A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma
•  NCT00107237: [1540] AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
•  NCT00105014: [1567] Interleukin-13 PE38QQR Immunotoxin and Radiation Therapy With or Without Temozolomide in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Malignant Glioma
•  NCT00103038: [1573] Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer
•  NCT00102648: [1486] Phase I Study of Sarasar and Temodar in Patients with Recurrent or Temodar-Refractory Glioblastoma Multiforme
•  * * * Duplicate ** NCT00102648: [726] A phase II study of temozolomide (continuous low dose) for the treatment of recurrent malignant glioma
•  NCT00099125: [1546] Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00093613: [1559] Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
•  NCT00090597: [1259] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  * * * Duplicate ** NCT00090597: [1122] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  NCT00089245: [868] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00085735: [28] Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
•  NCT00085566: [1485] Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
•  NCT00075387: [1495] Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
•  NCT00054496: [982] Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00052208: [1094] Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa) with Radiation Therapy in GBM
•  * * * Duplicate ** NCT00052208: [1112] Phase I/II Iressa + RT for treatment of previously untreated GBM.
•  NCT00049387: [995] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  * * * Duplicate ** NCT00049387: [1545] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00049127: [806] Phase I/II Trial of STI-571 (Gleevec) in Patients With Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00049127: [810] Phase I/II Study of Imatinib Mesylate (Gleevec ) in Patients With Recurrent Oligodendroglioma or Mixed Oligoastrocytoma
•  NCT00047281: [1281] Pilot study of Oral Thalidomide plus Cyclophosphamide for children with recurrent or progressive brain tumors.
•  NCT00042367: [19] Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
•  NCT00039572: [874] A Phase I/II Trial of Neutron Capture Therapy (NCT) for Glioblastoma Multiforme and Intracranial Melanoma
•  * * * Duplicate ** NCT00039572: [1479] Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
•  NCT00039468t: [1351] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039468: [1352] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039364: [1025] Open Label Phase II Study on STI571 Administered As a daily Oral Treatment In Gliomas
•  NCT00031083: [931] Phase 1 trial of IFN-Beta Gene Transfer in the Treatment of Glioblastoma Multiforme
•  * * * Duplicate ** NCT00031083: [334] Phase 2 Trial Of Recombinant Human Interferon Beta In The Treatment Of Patients With Recurrent Glioma
•  NCT00017147: [1113] Phase III O6 BG/BCNU + RT vs. BCNU + RT for treatment of GBM
•  NCT00014443: [1552] Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
•  NCT00008008 (Duplicate): [1565] Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma
•  NCT00006386: [905] RTOG 0023 A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme.
•  NCT00006355: [1032] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly diagnosed Glioblastoma Multiforme
•  * * * Duplicate ** NCT00006355: [813] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme.
•  * * * Duplicate ** NCT00006355: [847] A Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Malignant Glioma
•  * * * Duplicate ** NCT00006355: [742] NABTT Trial: Phase I/II Study of Pyraxolacridin (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme
•  NCT00006263: [935] Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
•  NCT00006238: [550] Phase I/II Evaluation of Phenylbutyrate in Adults with Recurrent Malignant Gliomas
•  NCT00006024: [938] A Phase I Study of Temozolomide and CCNU in Pediatric Patients with newly diagnosed Incompletely Resected Non-Brainstem High Grade Gliomas
•  NCT00005602: [937] Phase I Study of Concurrent Cereport and Carboplatin with Radiation Therapy for Children with Newly Diagnosed Brain Stem Gliomas
•  NCT00004259: [906] RTOG 9813 A Phase I/III Randomized Study of Radiation Therapy and Temozolomide versus Radiation Therapy and BCNU versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma.
•  * * * Duplicate ** NCT00004259: [1062] Phase I/II Randomized Study of Radiation Therapy and Temozolomide Versus Radiation Therapy and BCNU Versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma
•  * * * Duplicate ** NCT00004259: [864] SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU
•  NCT00004129: [585] Phase I Study of Interstitial Colloidal Phosphorus P32 in Patients With Recurrent or Poor Prognosis Grade 4 Astrocytoma
•  NCT00004073: [595] Phase II Study of Suramin and Concurrent Radiation Therapy in Newly Diagnosed GBM
•  NCT00004015: [1627] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  NCT00003916: [884] A Phase II Trial of Accelerated Radiotherapy using weekly sterotactic conformal boosts for supratentorial glioblastoma multiforme
•  NCT00003846: [604] Treatment of High Risk Central Nervous System Embryonal Tumors with Conventional Radiotherapy and Intensive Consolidation Chemotherapy with Peripheral Blood Progenitor Cell (PBSC) Support
•  NCT00003775: [503] Phase 2 open label study of SU101 for patients with anaplastic astrocytoma in first relapse
•  NCT00003751: [1068] Phase II Trial of Surgical Resection, Gliadel Wafer, and Irradiation Followed by Penicillamine/Low Copper Diet for Newly Diagnosed Glioblastoma Multiforme
•  NCT00003567 (Duplicate): [1564] Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin`s Lymphoma
•  NCT00003478: [1254] Phase I/II study of Anti-Tenascin Monoclonal Antibody 131I-Labeled 81C6 via surgically created cystic resection cavity in the treatment of patients with malignant CNS tumors.
•  NCT00003462: [1009] Intrathecal busulfan chemotherapy for patients with neoplastic meningitis (carcinomatous or lymphomatous meningitis).
•  NCT00003375: [945] RTOG 9802: A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase III Study of Radiation with or without PCV Chemotherapy in Unfavorable Low-Grade Glioma
•  * * * Duplicate ** NCT00003375: [560] Observation in Favorable Low-Grade Glioma and Phase III Study of RT +/- PCV Chemo in Unfavorable Low-Grade Glioma
•  NCT00003185: [121] Phase 1 Study of Adoptive Cellular Immunotherapy Plus IL-2 in Patients With Recurrent High Grade Gliomas or Metastases to the Brain.
•  NCT00003073: [958] A Randomizwed clinical study to determine the Patient Benefit and Safety of DEPOCYT(Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
•  NCT00002986: [1252] Phase II treatment with Topotecan plus BCNU for patients with primary malignant glioma.
•  NCT00002814: [386] Phase II study of Paclitaxel/Topotecan/G-CSF for recurrent glioblastoma multiforme or anaplastic astrocytoma
•  NCT00002619: [115] High dose chemotherapy with autologous stem cell rescue for patients aged less than 60 years with recurrent malignant brain tumors in "minimal" residual disease.
•  NCT00001807: [727] Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in patients who receive Neurotoxicic Therapy
•  NCT00001574: [599] Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic (NMRS) Imaging in Pediatric Patients with Primary Brain Tumors
•  HR# 18156: [1977] BIBW 2992 with or without Temozolomide in the treatment of patients with recurrent Malignant Glioma.
•  HR #18156: [1976]
•  724770: [1929] ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Malignant Glioma
•  06BG, BCNU: [966] SWOG S0001 Randomized trial of radiation + BCNU, +/- O6BG
•  01508117: [2058] A phase II window study of front-line Axitinib followed by Axitinib and radiation for Elderly patients with Glioblastoma Multiforme (GBM)
•  01227954: [2062] A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases
•  00892177: [2060] Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma
•  00869401: [2057] Phase I/Randomized Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM)
•  00777153: [1907] Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone
•  00114140: [1908] RTOG 0424 A Phase II Study of Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas